Form 8-K - Current report:
SEC Accession No. 0001213900-23-051347
Filing Date
2023-06-23
Accepted
2023-06-23 16:01:23
Documents
13
Period of Report
2023-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea180822-8k_abvcbiopharm.htm   iXBRL 8-K 27602
2 EMPLOYMENT AGREEMENT DATED AS OF JUNE 23, 2023, BY AND BETWEEN ABVC BIOPHARMA, I ea180822ex10-1_abvcbiopharm.htm EX-10.1 36431
  Complete submission text file 0001213900-23-051347.txt   244513

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abvc-20230623.xsd EX-101.SCH 2965
4 XBRL LABEL FILE abvc-20230623_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE abvc-20230623_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea180822-8k_abvcbiopharm_htm.xml XML 3494
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231037600
SIC: 2834 Pharmaceutical Preparations